| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/13/2004 | EP1465626A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 10/13/2004 | EP1465625A2 Solubilized topoisomerase poisons |
| 10/13/2004 | EP1465624A1 Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof |
| 10/13/2004 | EP1465623A1 Urea derivatives |
| 10/13/2004 | EP1465622A1 Use of ppar activators for the treatment of pulmonary fibrosis |
| 10/13/2004 | EP1465621A2 Compositions and methods of treatment involving peroxisome proliferator activated receptor gamma agonists and cyclooxygenase 2 selective inhibitors |
| 10/13/2004 | EP1465620A2 Novel composition of carvedilol |
| 10/13/2004 | EP1465619A1 Suppression of cartilage degradation via the estrogen receptor |
| 10/13/2004 | EP1465618A2 Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability |
| 10/13/2004 | EP1465617A1 Process for affecting neurologic progression |
| 10/13/2004 | EP1465616A1 Treatment of statin side effects using uridine derivatives |
| 10/13/2004 | EP1465614A2 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 10/13/2004 | EP1465613A2 Combination of mtp inhibitors or apob secretion inhibitors with fibrates for use as drugs |
| 10/13/2004 | EP1465612A1 Controlled release tablets of metformin |
| 10/13/2004 | EP1465611A2 Composition, synthesis and therapeutic applications of polyamines |
| 10/13/2004 | EP1465610A1 Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation |
| 10/13/2004 | EP1465609A2 Modulation of dopaminergic neurons |
| 10/13/2004 | EP1465608A1 Extended release compositions comprising as active compound venlafaxine hydrochloride |
| 10/13/2004 | EP1465607A1 Pharmaceutical formulations with modified release |
| 10/13/2004 | EP1465606A2 Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it |
| 10/13/2004 | EP1465605A1 Pravastatin pharmaceutical formulations and methods of their use |
| 10/13/2004 | EP1465604A1 Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms |
| 10/13/2004 | EP1465602A1 Matrix film tablets for the controlled release of natural mixtures of conjugated estrogen |
| 10/13/2004 | EP1465601A2 A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof |
| 10/13/2004 | EP1465599A1 Liposome composition for delivery of nucleic acid |
| 10/13/2004 | EP1465596A1 Polymeric gel system for the controlled delivery of codrugs |
| 10/13/2004 | EP1465593A1 Solid orally-dispersible pharmaceutical formulation |
| 10/13/2004 | EP1465592A2 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 10/13/2004 | EP1465591A1 Antibiotic product, use and formulation thereof |
| 10/13/2004 | EP1465590A2 Micelle compositions containing pegylated phospholipids and a photosensitizer |
| 10/13/2004 | EP1465577A2 Methods for improving the aesthetic appearance of skin |
| 10/13/2004 | EP1465563A1 METHOD OF SYSTEMICALLY DELIVERING SSRIs |
| 10/13/2004 | EP1465521A2 System and method for the pretreatment of the endplates of an intervertebral disc |
| 10/13/2004 | EP1465504A1 Matrix-forming composition containing pectin |
| 10/13/2004 | EP1465491A1 Antiseptic compositions and methods |
| 10/13/2004 | EP1465488A1 Arylamines as inhibitors of chemokine binding to us28 |
| 10/13/2004 | EP1430031A4 Kinetic resolution of a intermediate useful in the production of benazepril and analogues thereof |
| 10/13/2004 | EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 10/13/2004 | EP1381615B1 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H- [1,4]DIOXINO[2,3-e]INDOLE |
| 10/13/2004 | EP1381613B1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-(1,4)-benzodioxans |
| 10/13/2004 | EP1349547B1 Use of 5-aminolevulinic acid for the prophylaxis of restenosis |
| 10/13/2004 | EP1349539B1 Biocompatible composite |
| 10/13/2004 | EP1347987B1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 10/13/2004 | EP1343510A4 Light stabilized antimicrobial materials |
| 10/13/2004 | EP1322309A4 High affinity small molecule c5a receptor modulators |
| 10/13/2004 | EP1313510B1 Injectable pharmaceutical composition for systemic delivery of pharmacologically active compounds comprising medium chain triglycerides |
| 10/13/2004 | EP1313500B1 Combinations of dalfopristine/quinupristine with cefpirome |
| 10/13/2004 | EP1301188B1 Anthelmintic agents for preventing parasitic infections in humans and animals iii |
| 10/13/2004 | EP1289515B1 Pharmaceutical composition containing at least a polymer associated or conjugated with at least a phenylalkylcarboxylic acid salt, conjugate polymers and uses thereof |
| 10/13/2004 | EP1280797B1 Inhibitors of dipeptidyl peptidase iv |
| 10/13/2004 | EP1277750B1 Hydrates and crystals of a neuraminic acid compound |
| 10/13/2004 | EP1268472B1 3-aminopyrazole inhibitors of cyclin dependent kinases |
| 10/13/2004 | EP1267884B1 Compositions for use as penetration promoters in transdermal formulations for highly lipophilic active ingredients |
| 10/13/2004 | EP1261346A4 Modulation of cardiovascular injury |
| 10/13/2004 | EP1253921A4 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug |
| 10/13/2004 | EP1248603B1 Use of particular compounds for prophylaxis and treatment of hepatitis c |
| 10/13/2004 | EP1208089B1 Diazocin-dione derivatives and their use as tryptase inhibitors |
| 10/13/2004 | EP1207866B1 Delayed-action form of administration containing tramadol saccharinate |
| 10/13/2004 | EP1207840B1 Pharmaceutical compositions and methods for reducing the appearance of cellulite |
| 10/13/2004 | EP1206436B1 Retinoids for the treatment of emphysema |
| 10/13/2004 | EP1206253B1 Pharmaceutical preparations containing nanosols of chitosan, and their preparation |
| 10/13/2004 | EP1202965B1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 10/13/2004 | EP1202735B1 The use of a benzimidazole in the preparation of a medicament for the prevention of cancer. |
| 10/13/2004 | EP1202628B1 Novel hypoxanthine and thiohypoxanthine compounds |
| 10/13/2004 | EP1200151B1 Drug delivery device for insertion into the vagina, rectum or nasal cavity |
| 10/13/2004 | EP1187831B1 Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
| 10/13/2004 | EP1185529B1 Pyrazolobenzodiazepines as cdk2 inhibitors |
| 10/13/2004 | EP1177217B1 Amphiphile cyclodextrins, preparation and use thereof for solubilising organised systems and incorporating hydrophobic molecules |
| 10/13/2004 | EP1169038A4 Cyclic protein tyrosine kinase inhibitors |
| 10/13/2004 | EP1165533B1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 10/13/2004 | EP1165069B1 Antitumour synergistic composition |
| 10/13/2004 | EP1161245B1 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula |
| 10/13/2004 | EP1154786B1 Compositions for altering mucus secretion |
| 10/13/2004 | EP1152765B1 Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof |
| 10/13/2004 | EP1150954B1 Anti-imflammatory indole derivatives |
| 10/13/2004 | EP1144428B1 Method for preparing an aza-macrolide with 4"(r)-nh2 |
| 10/13/2004 | EP1135166B1 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 10/13/2004 | EP1131340B1 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 10/13/2004 | EP1128831B1 Pharmaceutical moxifloxacin preparation |
| 10/13/2004 | EP1124817B1 Method of preparing delta-9-tetrahydrocannabinol esters |
| 10/13/2004 | EP1107746B1 Methods of using and compositions comprising dopamine reuptake inhibitors |
| 10/13/2004 | EP1107745B1 Use of 5ht-6 antagonists for the treatment of adhd |
| 10/13/2004 | EP1102763B1 Fsh mimetics for the treatment of infertility |
| 10/13/2004 | EP1097142B1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 10/13/2004 | EP1093383B1 Drug delivery system comprising a homeobox peptide and a cytotoxic or antineoplastic drug |
| 10/13/2004 | EP1093366B1 Pharmaceutical composition containing gaba analogs and an antiviral agent to treat shingles |
| 10/13/2004 | EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 10/13/2004 | EP1079790B1 Use of microbicidal and spermicidal compositions for inactivating non-enveloped viruses |
| 10/13/2004 | EP1077956B1 3-substituted 5-aryl-4-isoxazolecarbonitriles having antiviral activity |
| 10/13/2004 | EP1055682B1 Novel substances kf-1040 and process for producing the same |
| 10/13/2004 | EP1030615A4 Spine distraction implant |
| 10/13/2004 | EP1027004A4 Spine distraction implant |
| 10/13/2004 | EP1007052B1 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception |
| 10/13/2004 | EP1005458B1 Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation |
| 10/13/2004 | EP1003762B1 Base analogues |
| 10/13/2004 | EP0999204B1 Novel compound having effect of promoting neuron differentiation |
| 10/13/2004 | EP0986389B1 Novel process |
| 10/13/2004 | EP0973818B1 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same |
| 10/13/2004 | EP0959792A4 Spine distraction implant and method |
| 10/13/2004 | EP0934928B1 Cyclic amine derivatives |